EBoDE Data Overview: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{study|moderator=Mori|stub=Yes}} category:EBoDE {| {{prettytable}} |+ TABLE 3-19. Summary of health endpoints, exposure units and exposure/response-relationships. Unless ot...") |
No edit summary |
||
| Line 2: | Line 2: | ||
[[category:EBoDE]] | [[category:EBoDE]] | ||
==Tables== | |||
===Table 1=== | |||
{| {{prettytable}} | {| {{prettytable}} | ||
|+ TABLE 3-19. Summary of health endpoints, exposure units and exposure/response-relationships. Unless otherwise stated, both mortality and morbidity were estimated. | |+ TABLE 3-19. Summary of health endpoints, exposure units and exposure/response-relationships. Unless otherwise stated, both mortality and morbidity were estimated. | ||
| Line 219: | Line 222: | ||
|- | |- | ||
|} | |} | ||
===Table 2=== | |||
Revision as of 12:59, 7 June 2011
This page is a study.
The page identifier is Op_en5232 |
|---|
| Moderator:Mori (see all) |
| This page is a stub. You may improve it into a full page. |
| Upload data
|
Tables
Table 1
| Stressor | Health endpoint | Population | Exposure estimate | Unit of exposure | Type of ERF | Point estimate of ERFa) | LCL (95%) | UCL (95%) | Reference(s) for ERF | Threshold | Calculation methodb) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Benzene | Leukemia | All | Annual mean exposure | µg m-3 | UR | 6.00 x 10-6 | 2.20 x 10-6 | 7.80 x 10-6 | WHO, 2000a; IRIS 2003 | 2A | |
| Dioxin | Total cancer incidence | All | Daily intake of adults | pg/kg/d | UR | 1.00 x 10-3 | 5.70 x 10-4 | 5.10 x 10-3 | NAS, 2004, IRIS, 2006, Leino 2008 | 2A | |
| SHS | Tracheas, bronchus and lung cancers c) | Adult non-smokers | % of people exposed (=yes) | yes/no | RR | 1.21 | 1.13 | 1.30 | US S.G., 2006 | 1A | |
| Ischemic heart disease | Adult non-smokers | yes/no | RR | 1.27 | 1.19 | 1.36 | US S.G., 2006 | 1A | |||
| Asthma induction | Adult non-smokers | yes/no | RR | 1.97 | 1.19 | 3.25 | Jaakkola et al., 2003 | 1A | |||
| Asthma induction | Children (<14 yr) | parental y/n |
RR | 1.32 | 1.24 | 1.41 | Cal-EPA, 2005 | 1A | |||
| Lower respiratory infections | Infants (<2 yr) | Parental y/n |
RR | 1.55 | 1.42 | 1.69 | US S.G., 2006 | 1A | |||
| Otitis media | Toddlers (<3 yr) | Parental y/n |
RR | 1.38 | 1.21 | 1.56 | Etzel et al., 1992; Cal-EPA 2005 | 1A | |||
| Formaldehyde | Asthma aggravation (children) (morbidity only) |
Toddlers (<3 yr) | Annual mean residential indoor concentration | µg m-3 | RR | 1.017 | 1.004 | 1.025 | Rumchev et al., 2002 | 100 | 1A |
| Lead | IQ loss | Children (<5 yr) | Distribution of blood lead levels | µg/l | UR | 0.051 | 0.032 | 0.07 | Landphear et al., 2005 | 24 | 2B |
| Mild mental retardation (morbidity only) |
Children (<5 yr) | µg/l | DS d) | function | - | - | - | 24 | 2B | ||
| Hypertensive diseases (morbidity only) |
Adults/All | µg/l | DS d) | function | - | - | - | 50 | 2B | ||
| Increased blood pressure | Adults/All | µg/l | UR | 2.50 x 10-2 | 1.70 x 10-2 | 3.20 x 10-2 | Fewtrell et al. 2003, Schwartz, 1995 | 50 | 2B | ||
| Road traffic noise | High sleep disturbance (HSD) (morbidity only) |
All | Persons exposed to predefined exposure categories | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B | |
| Ischemic heart disease (IHD) | All | Lday16h (dB) | OR | function | function | function | Babisch, 2006 | 1A | |||
| Railway noise | High sleep disturbance (HSD) (morbidity only) |
All | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B | ||
| Aircraft noise | High sleep disturbance (HSD) (morbidity only) |
All | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B |